Monte Rosa Almost Doubles — Up 94% — On A Massive Deal With Novartis

Monte Rosa Almost Doubles — Up 94% — On A Massive Deal With Novartis · Investor's Business Daily
ALLISON GATLIN
2 min read

In This Article:

Monte Rosa Therapeutics shares nearly doubled Monday on a deal with Novartis to develop treatments for immune system conditions.

Recommended Stories